Trial Search Results

Pregnancy and Developmental Outcomes After Transfer of Reportedly Aneuploid or Mosaic Embryos

To determine how often embryos reported to be abnormal by preimplantation genetic testing result in liveborn infants. To evaluate whether the pregnancies that result from these embryos are higher risk for complications and whether the resulting babies have higher risk for health or developmental issues in the first five years after birth.

Stanford is currently accepting patients for this trial.

Lead Sponsor:

Stanford University

Stanford Investigator(s):

Intervention(s):

  • Other: Non-euploid embryo transfer
  • Other: Euploid Transfer

Phase:

N/A

Eligibility


Inclusion Criteria:

   - Available aneuploid or mosaic embryos

   - No acceptable euploid embryos available

   - Willing to travel to Stanford for treatment

   - English language fluency

Exclusion Criteria:

   - Use of gestational carrier

   - Living outside the United States

   - Embryos with Trisomy 18, Trisomy 13 or Triploidy are not eligible for transfer in this
   protocol

Ages Eligible for Study

18 Years - 55 Years

Genders Eligible for Study

Female

Now accepting new patients

Contact Information

Stanford University
School of Medicine
300 Pasteur Drive
Stanford, CA 94305
Alleigh Boyd, MS
408-688-9749
Recruiting